Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

An Observational Study of the Medical-Grade Wireless Wearable Data for Predicting Hypoxemia Risk and Evaluating Workflow Efficiency in Patients Undergoing Sedated Gastrointestinal Endoscopy

15 novembre 2026 aggiornato da: Min Su

This prospective observational study aims to develop and evaluate prediction models for low blood oxygen levels (hypoxemia) in adult patients undergoing gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia. The study will also assess patient flow and waiting times during different stages of endoscopy care.

Low blood oxygen levels may occur during anesthesia and recovery from endoscopy. Medical-grade wireless wearable monitoring devices can continuously record vital signs as patients move through preparation, examination, transfer, and recovery areas. The investigators will analyze monitoring data, routine clinical information, and the time spent at different stages of care to identify factors associated with hypoxemia and potentially avoidable nonmedical waiting time.

This study will be conducted at the First Affiliated Hospital of Chongqing Medical University. Approximately 772 adult participants are planned for enrollment in the current study phase. All participants will receive routine anesthesia, endoscopy, monitoring, and recovery care. The study will not change clinical treatment decisions, and prediction model results will not be used to guide patient care.

The findings may support future improvements in patient safety monitoring, hypoxemia risk assessment, and endoscopy workflow efficiency. Participants may not receive any direct medical benefit from taking part in this study.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Descrizione dettagliata

Background and Rationale Hypoxemia is an important safety concern during gastrointestinal endoscopy under anesthesia. Changes in oxygen saturation may occur during both the procedure and the recovery period. Continuous monitoring using medical-grade wireless wearable devices may provide useful physiological data for predicting hypoxemia. In addition, the time required for different stages of endoscopy care may be influenced by patient characteristics, clinical needs, and operational factors. Distinguishing medically necessary care from avoidable nonmedical waiting may help improve workflow efficiency without compromising patient safety.

Study Design and Data Collection This investigator-initiated, prospective observational cohort study will be conducted at the First Affiliated Hospital of Chongqing Medical University. The current phase involves single-center model development and internal validation.

Adult patients scheduled for gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia will be assessed for eligibility and enrolled after written informed consent.

Medical-grade wireless wearable monitoring devices already used in routine clinical care will provide continuous physiological data, including peripheral oxygen saturation (SpO2), heart rate, and signal quality information. Additional study data will include routine pre-anesthesia assessments, patient characteristics, anesthesia and endoscopy records, airway management, recovery information, and workflow timestamps. Simple noninvasive measurements, including neck circumference and thyromental distance, will also be collected.

Hypoxemia Prediction Two prediction objectives will be evaluated. Model A will use information available before the first administration of anesthetic medication to predict hypoxemia occurring between the first anesthetic dose and endoscope removal.

Model B will evaluate the risk of hypoxemia during recovery, from completion of handover to the recovery area until the patient first meets discharge criteria. Development of Model B will depend on the availability of sufficient outcome events and data.

Hypoxemia will be defined as an SpO2 below 90%, after excluding measurement artifacts. Prediction models will be developed and internally validated using prespecified statistical and machine-learning methods. Additional temporal and external validation may be conducted in subsequent study phases after the required approvals.

Workflow Efficiency Assessment Standardized timestamps will be collected across patient check-in, preparation, monitoring, examination, transfer, recovery, discharge, and room turnover. Risk-adjusted analyses will assess variations in the duration of different workflow stages.

The main workflow efficiency outcome will be the cumulative duration of system-attributable nonmedical waiting time, confirmed by structured documentation of operational causes. Time required for necessary medical treatment, monitoring, and recovery will not be classified as avoidable waiting.

Patient Safety and Study Procedures This study is observational and will not alter routine anesthesia, endoscopy, monitoring, treatment, recovery, or discharge decisions. Prediction model results will not be disclosed to the clinical team for decision-making during the current study phase.

Research data will be de-identified and handled using appropriate data protection procedures. Available hospital records may be reviewed within 24 hours after discharge from the endoscopy center to identify relevant safety events. No additional invasive procedures or study-directed treatments will be performed.

Tipo di studio

Osservativo

Iscrizione (Stimato)

772

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, Cina, 400016
        • The First Affiliated Hospital of Chongqing Medical University
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study population will consist of adult patients aged 18 years or older who are scheduled to undergo gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia at the First Affiliated Hospital of Chongqing Medical University, China. Potential participants will be identified through routine pre-anesthesia assessment and outpatient clinical services. Eligible patients with an ASA-PS classification of I-III who receive routine medical-grade wireless wearable monitoring will be invited to participate after screening. Written informed consent will be obtained before enrollment. Approximately 772 participants are planned for the current single-center observational study.

Descrizione

Inclusion Criteria:

  • Adults aged 18 years or older.
  • Scheduled to undergo gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia, with routine medical-grade wireless wearable monitoring.
  • American Society of Anesthesiologists Physical Status (ASA-PS) classification I-III before anesthesia.
  • Able to understand the study information, voluntarily agree to participate, and provide written informed consent.

Exclusion Criteria:

  • Refusal to participate in the study.
  • Emergency endoscopy.
  • Preprocedural hypoxemia requiring advanced respiratory support.
  • Uncontrolled severe cardiopulmonary disease before the procedure.
  • Requirement for general anesthesia with endotracheal intubation, intensive care unit (ICU)-level support, or planned transfer to the ICU after the procedure.
  • Active major bleeding, a clearly full stomach, an anticipated difficult airway requiring a special anesthetic strategy, or other extremely high-risk conditions unsuitable for routine anesthesia management in an endoscopy center.
  • Missing critical outcome information that prevents determination of the primary safety outcome.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Patients Undergoing Gastrointestinal Endoscopy Under Anesthesia

This cohort consists of adult patients aged 18 years or older who are scheduled to undergo gastroscopy, colonoscopy, or combined gastrointestinal endoscopy under anesthesia at the First Affiliated Hospital of Chongqing Medical University. Eligible patients have an American Society of Anesthesiologists Physical Status (ASA-PS) classification of I-III and provide written informed consent. All participants receive routine anesthesia, endoscopic examination, and medical-grade wireless wearable monitoring according to standard clinical practice. Physiological monitoring data, clinical information, and workflow timestamps will be collected prospectively for hypoxemia prediction model development and workflow efficiency assessment. No additional study-directed clinical intervention will be performed.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Incidence of Hypoxemia During Gastrointestinal Endoscopy
Lasso di tempo: From the first administration of anesthetic medication until endoscope removal, during the endoscopy procedure.

The proportion of participants experiencing at least one episode of hypoxemia between the first administration of anesthetic medication (T6) and endoscope removal (T8). Hypoxemia is defined as peripheral oxygen saturation (SpO2) below 90% at any time, after exclusion of measurement artifacts caused by movement, poor perfusion, or sensor displacement. Events will be adjudicated using monitoring data and clinical records.

From the first administration of anesthetic medication until endoscope removal, during the endoscopy procedure.
Cumulative System-Attributable Nonmedical Waiting Time
Lasso di tempo: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.

The cumulative duration, in minutes, of system-attributable nonmedical waiting time per participant. Waiting episodes must have a documented operational cause, traceable start and end times, and no ongoing medical need for treatment, observation, or technical management. Operational causes include delays related to equipment, procedure rooms, staffing, recovery beds, transportation, handover, documentation, patient education, accompanying persons, cleaning, or supply preparation. Medically necessary care and recovery time will be excluded.

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Incidence of Hypoxemia During Postanesthesia Recovery
Lasso di tempo: From completion of handover to the postanesthesia recovery area until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of eligible participants experiencing hypoxemia (SpO2 below 90%, after artifact exclusion) after completion of handover to the recovery area (T10) and before first meeting discharge criteria (T12). The analysis will include participants without the recovery-period target event at T10 who have the required landmark variables. Formal model development is conditional on sufficient outcome events.

From completion of handover to the postanesthesia recovery area until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Severe Hypoxemia
Lasso di tempo: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of participants experiencing severe hypoxemia, defined as SpO2 below 75%, or SpO2 between 75% and 90% lasting at least 60 seconds, according to the study protocol.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Ratio of Hypoxemia Area Under the Curve to Duration
Lasso di tempo: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The area under the SpO2 curve for measurements below 90% divided by the cumulative duration of SpO2 below 90%, according to the prespecified analysis methodology.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Clinically Recognized Respiratory Events
Lasso di tempo: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The number and proportion of participants with clinically recognized apnea, airway obstruction, laryngospasm, bronchospasm, regurgitation, or aspiration. Event types will be reported separately.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Airway Interventions
Lasso di tempo: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The number and proportion of participants requiring positional adjustment, jaw thrust, increased oxygen flow, oropharyngeal or nasopharyngeal airway placement, positive-pressure mask ventilation, or unplanned tracheal intubation. Intervention types will be reported separately.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Hypotension
Lasso di tempo: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of participants with systolic blood pressure below 90 mmHg or a decrease greater than 30% from baseline. Treatment for hypotension will also be documented.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Incidence of Bradycardia
Lasso di tempo: From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.

The proportion of participants with heart rate below 50 beats per minute. Treatment for bradycardia will also be documented.

From the first administration of anesthetic medication until the participant first meets discharge criteria, on the day of the endoscopy procedure.
Occurrence of Major Clinical Complications
Lasso di tempo: From check-in at the endoscopy center through 24 hours after actual departure from the endoscopy center.

The number and type of major clinical complications, including severe gastrointestinal bleeding, gastrointestinal perforation, unplanned emergency department transfer, intensive care unit admission or hospitalization, cardiac arrest, and death. Individual event categories will be reported separately.

From check-in at the endoscopy center through 24 hours after actual departure from the endoscopy center.
Total Endoscopy Center Length of Stay
Lasso di tempo: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.

Total time in minutes from endoscopy center check-in (T1) to actual departure from the endoscopy center (T13).

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure.
Duration of Individual Endoscopy Workflow Stages
Lasso di tempo: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each consecutive workflow stage will be assessed separately.

Duration in minutes of each adjacent workflow stage from T1 through T13, including preparation, examination, transfer, recovery, and discharge-related stages. Stage-specific values will be reported.

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each consecutive workflow stage will be assessed separately.
Procedure Room Turnover Time
Lasso di tempo: From departure of the participant from the procedure area until the next patient enters the same procedure room, on the day of the endoscopy procedure.

Time in minutes from a participant leaving the procedure area (T9) until the next patient enters the same procedure room (T14). Prespecified exceptions will be excluded or reported separately.

From departure of the participant from the procedure area until the next patient enters the same procedure room, on the day of the endoscopy procedure.
Risk-Adjusted Excess Workflow Duration
Lasso di tempo: From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each workflow stage will be evaluated separately.

The difference between observed and expected workflow duration estimated using prespecified risk-adjusted stage-specific time models. Results will be evaluated by workflow stage.

From check-in at the endoscopy center until actual departure from the endoscopy center, on the day of the endoscopy procedure; each workflow stage will be evaluated separately.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Investigatore principale: Su Min, First Affiliated Hospital of Chongqing Medical University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 dicembre 2026

Completamento primario (Stimato)

30 aprile 2028

Completamento dello studio (Stimato)

30 aprile 2028

Date di iscrizione allo studio

Primo inviato

7 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

15 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

15 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • ZZ2026-0829-01

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

De-identified individual participant data (IPD) may be made available upon reasonable request to the corresponding author following publication of the primary study findings. Data sharing will be subject to approval by the relevant institutional ethics committee and execution of a data use agreement.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .